Clinical Trial Update: AZD8186 and Paclitaxel in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for AZD8186 combined with paclitaxel in advanced gastric cancer undergoing Phase 1 and Phase 2 exploration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor
• Stomach Cancer

Drugs mentioned

• AZD8186 (PI3K-beta inhibitor)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Solid Tumor, Stomach Cancer | Phase 1, Phase 2 | Status: UNKNOWN